CPDYOFGGEGFTOB-UHFFFAOYSA-N
C29H31F4N5O5S — CID 154540572
Data last refreshed: (MolForge compound catalog, from PubChem)
About CPDYOFGGEGFTOB-UHFFFAOYSA-N
CPDYOFGGEGFTOB-UHFFFAOYSA-N (PubChem CID 154540572) has the molecular formula C29H31F4N5O5S and a molecular weight of 637.66 g/mol. Its IUPAC name is 1-[4-[1-[(2,6-difluorophenyl)methyl]-3-(2,2-difluoropropyl)-5-[[2-methoxyethyl(methyl)amino]methyl]-2,4-dioxothieno[2,3-d]pyrimidin-6-yl]phenyl]-3-methoxyurea.
Molecular Properties
| Compound Name | CPDYOFGGEGFTOB-UHFFFAOYSA-N |
|---|---|
| PubChem CID | 154540572 |
| Molecular Formula | C29H31F4N5O5S |
| Molecular Weight | 637.66 g/mol |
| Exact Mass | 637.20 |
| IUPAC Name | 1-[4-[1-[(2,6-difluorophenyl)methyl]-3-(2,2-difluoropropyl)-5-[[2-methoxyethyl(methyl)amino]methyl]-2,4-dioxothieno[2,3-d]pyrimidin-6-yl]phenyl]-3-methoxyurea |
| SMILES | COCCN(C)Cc1c(-c2ccc(NC(=O)NOC)cc2)sc2c1c(=O)n(CC(C)(F)F)c(=O)n2Cc1c(F)cccc1F |
| InChI | InChI=1S/C29H31F4N5O5S/c1-29(32,33)16-38-25(39)23-20(14-36(2)12-13-42-3)24(17-8-10-18(11-9-17)34-27(40)35-43-4)44-26(23)37(28(38)41)15-19-21(30)6-5-7-22(19)31/h5-11H,12-16H2,1-4H3,(H2,34,35,40) |
| InChIKey | CPDYOFGGEGFTOB-UHFFFAOYSA-N |
| XLogP | 4.63 |
| TPSA | 106.83 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 12 |
| Heavy Atoms | 44 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 637.66 |
| LogP ≤ 5 | 4.63 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 9 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 154540572 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.